{"nctId":"NCT01387737","briefTitle":"Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus","startDateStruct":{"date":"2011-05"},"conditions":["Type 2 Diabetes Mellitus"],"count":1299,"armGroups":[{"label":"TA-7284-Low","type":"EXPERIMENTAL","interventionNames":["Drug: TA-7284-Low"]},{"label":"TA-7284-High","type":"EXPERIMENTAL","interventionNames":["Drug: TA-7284-High"]}],"interventions":[{"name":"TA-7284-Low","otherNames":[]},{"name":"TA-7284-High","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Men or women age ≥20 years old\n* Diagnosed with Type 2 diabetes mellitus at least 3 months before screening\n* HbA1c of ≥7.0% and ≤10.0% (monotherapy group)\n* HbA1c of ≥7.0% and ≤10.5% (combination therapy group)\n\nExclusion Criteria:\n\n* Type I diabetes mellitus, diabetes mellitus resulting from pancreatic disorder, secondary diabetes mellitus\n* Past or current history of severe diabetic complications\n* Fasting plasma glucose \\> 270 mg/dL before treatment start\n* History of hereditary glucose-galactose malabsorption or primary renal glucosuria\n* Patients requiring insulin therapy","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Safety and Tolerability Assessed by Adverse Events, Hypoglycemic Events","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"81.8","spread":null},{"groupId":"OG001","value":"82.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.9","spread":null},{"groupId":"OG001","value":"13.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in HbA1c","description":null,"classes":[]},{"type":"SECONDARY","title":"Change in Fasting Plasma Glucose","description":null,"classes":[]},{"type":"SECONDARY","title":"Change in Body Weight","description":null,"classes":[]},{"type":"SECONDARY","title":"Change in Blood Pressure","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":30,"n":584},"commonTop":["Nasopharyngitis","Hypoglycaemia unawareness","Upper respiratory tract inflammation","Hypoglycaemia","Constipation"]}}}